Why FedEx Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
AADI BIOSCIENCE INC AADI | 3.02 | -16.11% |
Aptose Biosciences Inc. APTO | 0.21 | -3.86% |
CANDEL THERAPEUTICS, INC. CADL | 7.77 | -5.01% |
Cara Therapeutics Inc CARA | 4.66 | -1.89% |
Clearwater Paper Corporation CLW | 28.89 | +0.17% |
Shares of FedEx Corporation (NYSE:FDX) rose sharply in today's pre-market trading as the company posted stronger-than-expected results for its second quarter.
The company also announced that it has decided to pursue a full separation of FedEx Freight through the capital markets, creating a new publicly traded company.
FedEx shares jumped 8.7% to $299.80 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
Gainers
- Aptose Biosciences Inc. (NASDAQ:APTO) gained 80.5% to $0.3070 in pre-market trading after the company announced it was granted an extension to provide compliance evidence for a continued Nasdaq listing.
- Psyence Biomedical Ltd. (NASDAQ:PBM) gained 67.4% to $4.12 in pre-market trading fater jumping more than 60% on Thursday. The company announced it has entered into an IP licensing and mutual exclusivity agreement with Optimi Health Corp.
- Ocean Biomedical, Inc. (NASDAQ:OCEA) climbed 62.5% to $0.9576 in pre-market trading.
- Nvni Group Limited (NASDAQ:NVNI) gained 52.8% to $4.08 in pre-market trading after jumping 317% on Thursday.
- Humacyte, Inc. (NASDAQ:HUMA) rose 44.5% to $5.00 in pre-market trading as the company announced the FDA approval of SYMVESS™ (acellular tissue engineered vessel-tyod) for the treatment of extremity vascular trauma.
- Aadi Bioscience, Inc. (NASDAQ:AADI) gained 35.3% to $3.14 in pre-market trading after the company secured $100 million PIPE financing and announced the sale of FYARRO for $100 million.
- Xilio Therapeutics, Inc. (NASDAQ:XLO) gained 26.9% to $1.19 in pre-market trading after the company announced 7.85 million of its shares was acquired by Gilead Sciences.
- ZJK Industrial Co., Ltd. (NASDAQ:ZJK) rose 17.4% to $8.78 in pre-market trading after dipping over 12% on Thursday.
- Clearwater Paper Corporation (NYSE:CLW) gained 11.8% to $27.62 in pre-market trading.
Losers
- Molecular Templates, Inc. (NASDAQ:MTEM) shares tumbled 49.5% to $0.1785 in pre-market trading after the company announced notice of delisting and failure to satisfy continued listing rules.
- PainReform Ltd. (NASDAQ:PRFX) declined 36.4% to $7.10 in pre-market trading after jumping around 410% on Thursday.
- Cara Therapeutics, Inc. (NASDAQ:CARA) shares fell 26.7% to $0.2998 in pre-market trading after jumping 56% on Thursday. Cara Therapeutics recently announced it entered into an all-stock merger with Tvardi Therapeutics.
- Novo Nordisk A/S (NYSE:NVO) fell 25.8% to $76.80 in pre-market trading. Novo Nordisk said CagriSema demonstrated weight loss in adults with obesity or overweight in the REDEFINE 1 trial.
- XChange TEC.INC (NASDAQ:XHG) shares dipped 25.2% to $0.9730 in pre-market trading after climbing 65% on Thursday.
- Mobix Labs, Inc. (NASDAQ:MOBX) fell 24.5% to $1.57 in today's pre-market trading after reporting third-quarter results.
- Zoomcar Holdings, Inc. (NASDAQ:ZCAR) dipped 23.6% to $1.94 in pre-market trading. Zoomcar said it launched Zoomcar Cabs, which are affordable car rentals with drivers as a new offering.
- Mesoblast Limited (NASDAQ:MESO) shares fell 18.1% to $13.72 in pre-market trading. Mesoblast shares jumped over 36% on Thursday after the company announced the FDA approved Ryoncilas the first mesenchymal stromal cell therapy in the United States.
- Candel Therapeutics, Inc. (NASDAQ:CADL) fell 13.1% to $8.66 in pre-market trading after jumping over 52% on Thursday.
- Quantum Computing Inc. (NASDAQ:QUBT) fell 11.1% to $13.46 in pre-market trading after declining 41% on Thursday.
Now Read This:
- S&P 500, Nasdaq End In Red As Investor Sentiment Declines, Micron Tumbles After Sales Miss: Greed Index In ‘Extreme Fear’ Zone
